InspireMD Inc
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
NSPR$0.71+2.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(U.S. dollars in thousands)
| September 30, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $15,818 | $9,640 |
| Marketable securities | 24,584 | 29,383 |
| Accounts receivable: | ||
| Trade, net | 1,530 | 1,804 |
| Other | 741 | 648 |
| Prepaid expenses | 1,276 | 578 |
| Inventory | 2,445 | 2,106 |
| TOTAL CURRENT ASSETS | 46,394 | 44,159 |
| NON-CURRENT ASSETS: | ||
| Property, plant and equipment, net | 1,946 | 1,060 |
| Operating lease right of use assets | 1,145 | 1,473 |
| Fund in respect of employee rights upon retirement | 996 | 951 |
| TOTAL NON-CURRENT ASSETS | 4,087 | 3,484 |
| TOTAL ASSETS | $50,481 | $47,643 |
CONDENSED CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands other than share and per share data)
| September 30, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| LIABILITIES AND EQUITY | ||
| CURRENT LIABILITIES: | ||
| Accounts payable and accruals: | ||
| Trade | 1,305 | 939 |
| Other | 5,960 | 5,081 |
| TOTAL CURRENT LIABILITIES | 7,265 | 6,020 |
| LONG-TERM LIABILITIES- | ||
| Operating lease liabilities | 682 | 1,038 |
| Liability for employees’ rights upon retirement | 1,183 | 1,084 |
| TOTAL LONG-TERM LIABILITIES | 1,865 | 2,122 |
| COMMITMENTS AND CONTINGENT LIABILITIES | - | |
| TOTAL LIABILITIES | 9,130 | 8,142 |
| EQUITY: | ||
| Common stock, par value $0.0001 per share; 150,000,000 shares authorized at September 30, 2024 and December 31, 2023; 25,719,632 and 21,841,215 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively | 3 | 2 |
| Preferred C shares, par value $0.0001 per share; 1,172,000 shares authorized at September 30, 2024 and December 31, 2023; 1,718 shares issued and outstanding at September 30, 2024 and December 31 2023, respectively | -* | -* |
| Additional paid-in capital | 285,680 | 261,000 |
| Accumulated deficit | (244,332) | (221,501) |
| Total equity | 41,351 | 39,501 |
| Total liabilities and equity | $50,481 | $47,643 |
| * | Represents an amount less than $1 thousand |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.